Exploration of novel 20S proteasome activators featuring anthraquinone structures and their application in hypoxic cardiomyocyte protection
Qian Yu(Union Hospital), Huajian Zhu(China Pharmaceutical University), Jiaan Shao(Hangzhou Xixi hospital), Yubo Zhou(Shanghai Institute of Materia Medica), Yubing Han(Shanghai Institute of Materia Medica), Linghui Zeng(Zhejiang University), Jianjun Xi(Hangzhou Xixi hospital), Jinxin Che(Pharmaceutical Biotechnology (Czechia)), Chong Zhang(Nanjing University of Information Science and Technology), Lee Jia(Henan University), Yizhou Xu(Westlake University), Jiankang Zhang(Westlake University), Lixin Gao(Shanghai Institute of Materia Medica), Yu Cao(Shanghai Institute of Materia Medica), Linhao Xu(Hangzhou First People's Hospital), Linjie Li(Shanxi Provincial Cancer Hospital), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University), Liteng Shen(Zhejiang Lab)
Cited by 1
Related Papers
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Methanotrophs: Multifunctional bacteria with promising applications in environmental bioengineering
|Biochemical Engineering Journal|2010|208
<p>Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT</p>
|OncoTargets and Therapy|2019|120